Can You Take Lexapro and Lamictal Together?

Lexapro (escitalopram) and Lamictal (lamotrigine) are prescribed together regularly, and the combination is generally considered safe. The two drugs work through different brain pathways, which is part of why clinicians pair them: escitalopram raises serotonin levels while lamotrigine calms overactive nerve signals through sodium channels. Their pharmacokinetic profiles overlap very little, meaning one drug does not dramatically change how the body processes the other. That said, the combination comes with its own set of things to watch for, and the evidence supporting it varies depending on the condition being treated.

Why Doctors Pair These Two Medications

The most common reason you will see escitalopram and lamotrigine prescribed together is bipolar disorder with a prominent depressive component. Lamotrigine is FDA-approved for maintenance treatment of bipolar disorder, where it is particularly useful at preventing depressive episodes. But lamotrigine on its own does not always fully control mood symptoms, and adding an SSRI like escitalopram can help manage residual depression or co-occurring anxiety. This combination lets the clinician address mood cycling with one drug and persistent low mood or worry with the other.

A second scenario is treatment-resistant unipolar depression. When escitalopram alone has not produced an adequate response after a reasonable trial, lamotrigine is sometimes added as an augmentation strategy. A third scenario involves people with epilepsy who also have depression. Lamotrigine works as an anti-seizure medication on its own, and escitalopram can be layered on top to treat the depressive symptoms that frequently accompany epilepsy.

How the Two Drugs Work in the Brain

Escitalopram targets the serotonin transporter, a protein responsible for pulling serotonin back into the neuron after it has been released. By blocking that transporter, escitalopram allows more serotonin to remain in the space between neurons, boosting serotonin signaling. What makes escitalopram somewhat unusual among SSRIs is that it also binds to a secondary site on the transporter, slowing its own detachment and potentially extending its action at the primary binding site.¹

Lamotrigine works in a completely different part of the neurochemical landscape. It inhibits sodium channels on neurons, which reduces the rapid, repetitive firing that characterizes seizure activity. A downstream effect of calming that excessive firing is a reduction in glutamate release, the brain’s main excitatory neurotransmitter.² This glutamate-dampening action is thought to be part of why lamotrigine helps stabilize mood in bipolar disorder and why it has been studied as a depression add-on. Since escitalopram works on serotonin and lamotrigine works on sodium channels and glutamate, the two drugs are not stepping on each other’s pharmacological toes. They operate through essentially independent mechanisms.

Evidence for Lamotrigine Added to an Antidepressant in Stubborn Depression

When an SSRI like escitalopram is not working well enough on its own for unipolar depression, adding lamotrigine is one strategy clinicians sometimes reach for. The evidence here is mixed but leans cautiously positive, especially for people with more severe and longer-lasting illness.

An open-label study that tracked patients on antidepressants who then added lamotrigine found statistically significant improvements in depressed mood, loss of interest, anxiety, energy, and cognitive difficulties as early as a few weeks into lamotrigine augmentation. Those gains held through follow-up assessments at three, six, and twelve months.³ That study was unblinded, though, meaning both patients and doctors knew lamotrigine was being added, which introduces the possibility that expectations influenced results.

A meta-analysis that pooled results from multiple trials found that lamotrigine augmentation did improve depression scores and response rates compared to control groups. The benefit appeared stronger in patients who had been ill longer and whose depression was more severe. Interestingly, the improvement was larger in patients taking SSRIs specifically than in those taking serotonin-norepinephrine reuptake inhibitors, which is relevant if your baseline antidepressant is escitalopram.⁴

On the other hand, a randomized, placebo-controlled, double-blind trial, the gold standard design, found no significant advantage for lamotrigine over placebo when added to antidepressants in treatment-resistant depression. The authors noted that their sample was small and the patients were particularly chronic and treatment-refractory, which may have made it harder to detect a benefit.⁵

What should you take from these conflicting results? Lamotrigine augmentation is not a sure thing for treatment-resistant depression. The evidence is more encouraging in people with more severe, longer-duration illness and in those already on SSRIs. But it is not the kind of robust, replicated finding that would make it a first-line augmentation choice. Most prescribing guidelines still list options like lithium, atypical antipsychotics, or thyroid hormone ahead of lamotrigine for depression augmentation. When those options have failed or are not tolerable, lamotrigine becomes a reasonable trial.

When Epilepsy and Depression Overlap

Depression is surprisingly common in people with epilepsy, affecting roughly a third of epilepsy patients at some point. This creates a practical problem: the person needs both a seizure medication and an antidepressant, and the two drugs need to play nicely together. Lamotrigine combined with escitalopram has been directly studied in this context.

A clinical trial comparing two anti-seizure drugs, each combined with escitalopram, in patients who had both epilepsy and depression found that both combinations effectively reduced seizure frequency and improved quality of life. But the lamotrigine-plus-escitalopram group showed a stronger antidepressant effect and better tolerability, with patients reporting fewer side effects and higher satisfaction with treatment.⁶ This makes lamotrigine a particularly appealing choice for patients who need seizure control and who also have depressive symptoms that call for an SSRI. The combination addresses both conditions without requiring a third medication.

Drug Interaction Profile

One of the practical advantages of the escitalopram-lamotrigine pairing is that the two drugs have minimal pharmacokinetic interference. Lamotrigine is not primarily processed through the cytochrome P450 liver enzyme system that handles most other drugs. Instead, it is cleared mainly through a different metabolic pathway called glucuronidation. Escitalopram, unlike some other SSRIs such as fluoxetine or paroxetine, is only a mild inhibitor of the P450 enzymes. A review of antidepressant and anti-seizure drug interactions noted that the SSRIs most likely to cause clinically meaningful interactions are fluoxetine, paroxetine, and fluvoxamine, all of which are moderate to strong P450 inhibitors.⁷ Escitalopram, by contrast, is far less likely to push lamotrigine levels up or down in a way that would be clinically concerning.

The same review pointed out that the anti-seizure drugs most likely to alter antidepressant levels are the older enzyme-inducing ones like carbamazepine, phenobarbital, and phenytoin, as well as valproic acid. Lamotrigine does not meaningfully induce or inhibit the enzymes that break down escitalopram, so it should not reduce escitalopram’s effectiveness or cause it to accumulate. This bidirectional lack of interference is a genuine advantage of this particular combination over many alternatives.

Side Effects Worth Knowing About

Every medication combination carries its own risk profile. Even though escitalopram and lamotrigine do not interfere much with each other’s metabolism, combining them introduces some side effect considerations you should be aware of.

Myoclonus

Myoclonus refers to sudden, involuntary muscle jerks, the kind of movement you might experience as you are falling asleep, except occurring during waking hours and sometimes severely enough to interfere with daily function. A published case report described myoclonus developing in a patient receiving both lamotrigine and escitalopram.⁸ Both drugs can independently lower the threshold for myoclonus through different pathways: escitalopram through serotonin enhancement, lamotrigine through its effects on neural excitability. While this appears to be uncommon, it is something to flag with your prescriber if you notice twitching or jerking movements after starting or adjusting either drug.

Serotonin Syndrome Risk

Serotonin syndrome is a potentially dangerous condition caused by too much serotonin activity in the brain. Symptoms range from mild, like agitation and diarrhea, to life-threatening, including high fever, muscle rigidity, and seizures. The primary risk factor is combining two or more drugs that increase serotonin levels. Escitalopram, as an SSRI, inherently increases serotonin. Lamotrigine is not primarily a serotonergic drug, but it has appeared in case reports of serotonin syndrome. A systematic review of anti-seizure drugs linked to serotonin syndrome found that lamotrigine was the second most commonly implicated anti-seizure medication, appearing in about 29% of the cases reviewed. However, the vast majority of those patients, roughly 88%, were also taking other serotonergic drugs at the same time.⁹

The practical takeaway: the risk of serotonin syndrome from escitalopram plus lamotrigine alone is low. But the risk climbs if you add a third serotonin-boosting substance, whether that is another prescription drug like tramadol, an over-the-counter supplement like St. John’s wort, or a recreational substance like MDMA. If you are taking both of these medications, make sure every provider you see, including dentists and urgent care doctors, knows your full medication list.

Lamotrigine Rash

This is not really about the combination per se, but it is the most important safety issue with lamotrigine that anyone starting it needs to understand. Lamotrigine can cause serious skin reactions, including Stevens-Johnson syndrome, a rare but potentially life-threatening blistering condition. In clinical trials, serious rashes leading to hospitalization occurred in roughly one in 300 adults. The risk increases significantly when lamotrigine is started too quickly or is combined with valproic acid.¹⁰ Escitalopram does not appear to increase this rash risk. The standard precaution is a very slow dose titration when starting lamotrigine, typically beginning at 25 mg per day and increasing in small steps over several weeks. If you develop any new rash, especially one that is spreading or accompanied by fever, mouth sores, or general malaise, you should contact your doctor immediately. Most lamotrigine rashes are benign, but they are all taken seriously because the dangerous ones look mild at first.

Practical Considerations When Starting Both

If your prescriber wants to put you on both escitalopram and lamotrigine, the standard approach is to avoid starting them at the same time. Introducing two new medications simultaneously makes it impossible to tell which one is causing any side effects that appear. The more typical sequence is to stabilize on one drug first, then add the second. If lamotrigine is the one being added, it will be titrated up very slowly regardless of whether you are already on escitalopram, because of the rash risk described above. This means it can take six weeks or more to reach a therapeutic dose of lamotrigine.

Dosing ranges for the two drugs in combination are generally the same as they would be individually. Escitalopram for depression or anxiety is usually prescribed at 10 to 20 mg per day. Lamotrigine doses vary more widely depending on the indication. For bipolar maintenance, doses typically range from 100 to 200 mg per day. For epilepsy, doses can be higher. Because the two drugs do not significantly alter each other’s blood levels, one does not usually need to be adjusted because of the other.

Side effects you are most likely to notice from the combination are the familiar ones from each individual drug: nausea, headache, and sexual side effects from escitalopram; dizziness, drowsiness, and possible headache from lamotrigine. Some people report that lamotrigine is relatively gentle on sleep and libido compared to many other psychiatric medications, which can make it a more tolerable long-term partner for an SSRI.

Hormonal Contraception and Lamotrigine Levels

This is a tangential but frequently overlooked issue for anyone on lamotrigine who takes hormonal birth control. Estrogen-containing contraceptives, like the combined pill, can significantly lower lamotrigine blood levels, sometimes cutting them nearly in half. This happens because estrogen accelerates the glucuronidation pathway that clears lamotrigine from the body. When the hormone-free week of the pill pack arrives, lamotrigine levels can spike back up, creating a roller-coaster pattern of too little medication during active pill weeks and too much during the placebo week.

This interaction does not involve escitalopram at all, but it is critical to know about because it can destabilize mood or seizure control in ways that get mistakenly blamed on the lamotrigine-escitalopram combination or on the underlying condition worsening. If you are on both lamotrigine and a hormonal contraceptive, your prescriber may need to adjust your lamotrigine dose, switch you to a progestin-only contraceptive, or use a continuous dosing schedule that avoids hormone-free intervals. Any changes to your contraceptive method should prompt a conversation about whether your lamotrigine dose needs re-evaluation.

When This Combination Might Not Be the Right Fit

While escitalopram and lamotrigine work well together for many people, there are situations where the combination deserves extra caution. If you have a history of serious drug rashes or known hypersensitivity to lamotrigine, the rash risk may outweigh the benefit. If you are already taking other medications that raise serotonin levels, adding both an SSRI and a drug with even mild serotonergic potential increases the cumulative risk. People with kidney or liver impairment may clear lamotrigine more slowly, which could require lower doses and more careful monitoring.

There is also the question of whether lamotrigine is contributing meaningfully if it is being used for depression augmentation. Given that the evidence for this use is mixed, your prescriber should revisit whether lamotrigine is pulling its weight after an adequate trial, typically around two to three months at a therapeutic dose. If your depression has not improved, continuing a medication that is not helping exposes you to its risks without the offsetting benefit. That conversation is worth initiating if you feel the combination is not making a difference.

For people with bipolar disorder, the calculus is different because lamotrigine’s mood-stabilizing role is better established. In that context, the question is usually not whether to keep lamotrigine but whether escitalopram is the best SSRI to pair with it, and whether SSRI use carries any risk of triggering a manic or hypomanic switch. Most clinicians consider escitalopram to be among the lower-risk SSRIs for mania induction, but the risk is not zero, and it is higher in bipolar I than bipolar II. Close monitoring for early signs of hypomania, like decreased need for sleep or uncharacteristic energy and impulsivity, is standard practice when adding any antidepressant to a mood stabilizer.